Protean Presents on the Use of Image Analysis for the Risk Classification of Barrett’s Esophagus
Barrett’s esophagus is a common condition that occasionally progresses to become invasive and possibly fatal cancer. Improved classification and early treatment could result in improved outcomes for patients and lower costs to the health system overall. Protean is focused on improving diagnosis for Barrett’s esophagus condition using advanced methods including image analysis and the use of artificial intelligence.
Protean has partnered with Florida Digestive Specialists to perform this collaborative research study.
Poster Presented at USCAP 2022:
Poster #58, 1-4PM PDT
About Protean BioDiagnostics
Protean BioDiagnostics is revolutionizing modern healthcare with our Protean MAPS™ system, which integrates health screening, diagnostics, treatment guidance, and tele-medicine backed decision support.
We collaborate with physicians and health groups to support them in providing the best possible care for their patients, regardless of where they live.